Detalhe da pesquisa
1.
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS.
J Neuroinflammation
; 20(1): 106, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138340
2.
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.
Proc Natl Acad Sci U S A
; 117(9): 5028-5038, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071226
3.
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.
Acta Neuropathol
; 144(2): 259-281, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666306
4.
Oncostatin M, an Underestimated Player in the Central Nervous System.
Front Immunol
; 10: 1165, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31191538